New research has determined an immune mechanism responsible for graft failure in a mouse model of in utero blood cell transplantation, a procedure that could be used to treat human congenital blood disorders. As fetal immune cells were triggered to eliminate the transplanted blood cells by immune molecules obtained from the mother’s breast milk, the authors suggest that it should be possible to develop approaches to insure this approach is successful in the clinic.